Vaccines: Does Europe Do Them Better?

Episode Summary

Executive Summary: The episode examines the CDC’s newly reduced childhood vaccine recommendations and the U.S. government’s claim that they’re being aligned with countries like Denmark. Through interviews with Danish and U.S. experts, the show argues that vaccine schedules depend on disease prevalence, health-system capacity, and risk tolerance—not simple cross-country copying—and warns the changes may confuse parents, reduce uptake, and ultimately weaken protection against preventable diseases.

Main Topics: CDC’s revised childhood vaccine schedule (Priority: 5/5): The episode opens with the federal government scaling back routine childhood vaccine recommendations from 17 diseases to 11, shifting several shots to high-risk or shared-decision categories. Using Denmark as a model (Priority: 5/5): The U.S. administration cites Denmark and other peer countries as justification for fewer vaccines, prompting a discussion of why Denmark’s schedule is different and whether it is transferable. How countries decide which vaccines to recommend (Priority: 4/5): Danish expert Jens Lundgren explains that vaccine effectiveness, cost, disease frequency, and local health-system realities all influence recommendations. Why context matters for public health (Priority: 5/5): Experts argue that targeted vaccination strategies require fast detection, strong contact tracing, and reliable healthcare access—conditions that are weaker in the U.S. than in Denmark. Specific vaccines affected: meningococcal disease, rotavirus, RSV, hepatitis A (Priority: 5/5): The episode uses these vaccines to show how the new guidance may make routine prevention less straightforward, even when diseases are rare, serious, or costly to treat. Confusion, access, and future risk (Priority: 4/5): Doctors and parents describe the new recommendations as confusing and potentially destabilizing, worrying that technical access may remain but practical uptake will drop over time.

Key Arguments: The CDC’s changes are not driven by new evidence that vaccines are unsafe, but by a political push to align with other countries’ schedules. Counting 72 shots refers to cumulative shots through age 18, not 72 shots given to babies. A disease can be rare precisely because vaccination has kept it rare; using current rarity to justify reduced vaccination can be misleading. Countries like Denmark consider local disease prevalence, healthcare access, and treatment capacity before recommending universal vaccination. Some diseases that are rare in wealthy countries still cause severe illness, hospitalization, or death, so routine vaccination can prevent major harm. Copying another country’s vaccine schedule ignores differences in health systems, outbreak response capacity, and population risk. Targeted vaccination strategies depend on rapid case detection and contact tracing, which are harder in fragmented systems like the U.S. Even when vaccines remain technically available, moving them to case-by-case categories creates confusion and may lower uptake. The American Academy of Pediatrics still supports the earlier, broader schedule and clinicians may continue recommending it. Experts expect more barriers and erosion of trust if the federal government continues to de-emphasize routine vaccination.

Data Points: Previous CDC routine childhood vaccine coverage: 17 diseases - Before the new CDC change, every child was recommended to be vaccinated against 17 diseases. New CDC routine childhood vaccine coverage: 11 diseases - The revised schedule now recommends routine vaccination against 11 diseases. Number of diseases removed from universal recommendation: 6 - Hepatitis A, hepatitis B, meningitis/meningococcal disease, RSV, rotavirus, and flu were moved away from routine universal recommendations. Cumulative shots by age 18: 72 shots - A social media graphic cited by Trump referred to total shots across childhood and adolescence, including annual flu and COVID shots. Meningococcal disease incidence: Less than 1 case per 100,000 people per year - Used to explain why Denmark may not recommend universal vaccination for all children. Meningococcal disease fatality in the U.S.: 10% to 15% - Approximate share of U.S. cases that can be fatal. Meningococcal cases prevented by U.S. vaccine program: About 500 cases and 54 deaths - Modeling estimate over roughly 15 years. Rotavirus burden prevented annually: 62,000 emergency department visits and 45,000 hospitalizations - CDC estimate of the vaccine’s yearly prevention impact in the U.S. U.S. cases of hepatitis A in the 1990s: Widespread community transmission - Used to show that vaccines can eliminate routine spread without eradicating the virus entirely. Denmark’s known meningococcal cases in 2024: 26 cases - Illustrates how rare the disease is, while also showing the need for targeted outbreak response. Close contacts identified in Denmark’s 2024 meningococcal response: More than 100 people - Authorities traced contacts and recommended vaccination. Confirmed vaccination among close contacts in Denmark: About half - Only around half of identified contacts were confirmed to have been vaccinated.

Pivotal Quotes: "It is like watching a train wreck in slow motion." — Unnamed expert (quoted by the episode from an international source): Reaction from a foreign vaccine expert about the U.S. policy shift. "You can't copy and paste a vaccine schedule from another country and expect it to work in the same way that it does in a different context like the U.S." — David Higgins: Explaining why Denmark’s schedule cannot simply be transplanted to the United States. "Vaccines are victims of their own success." — David Higgins: Describing how successful vaccination makes diseases seem unnecessary or less urgent to prevent.

Implications: The changes may increase confusion, reduce routine uptake, and make it harder for families to access vaccines later. If trust and coverage erode, preventable diseases like measles, RSV, hepatitis A, and rotavirus could resurge.